Annual revenue went from KRW 6.77 trillion in 2022 to KRW 6.29 trillion in 2023 (down 7.2% year on year), then KRW 6.66 trillion in 2024 (up 5.9%) and KRW 6.48 trillion in 2025 (down 2.6%). Among 2022 to 2025, 2022 was the largest year and 2023 the smallest.
Operating profit fell from KRW 467.7 billion in 2022 to KRW 312.5 billion in 2023 (down 33.2%), recovered to KRW 471.1 billion in 2024 (up 50.7%) and was KRW 427.6 billion in 2025 (down 9.2%).
Operating margin was 6.9% in 2022, 5.0% in 2023, 7.1% in 2024 and 6.6% in 2025, so 2024 was the highest margin year in the period.
Net income attributable to controlling shareholders rose from KRW 33.9 billion in 2022 to KRW 212.7 billion, KRW 310.6 billion and KRW 1.54 trillion in 2025, marking three consecutive annual increases from 2023 to 2025.
In 2025, that profit rose 395.4% even as operating profit declined, so the two measures moved in opposite directions. Total net income including non-controlling interests was the same KRW 1.54 trillion in 2025.
The debt-to-equity ratio fell from 160.1% at end-2024 to 114.8% at end-2025, with total equity of KRW 7.82 trillion and total liabilities of KRW 8.98 trillion. Operating cash flow was KRW 789.5 billion in 2025, up from KRW 596.8 billion in 2024.
On a quarterly basis, operating profit fell from KRW 117.3 billion in Q3 2025 to KRW 66.5 billion in Q4 2025 (down 43.3% quarter on quarter), recovered to KRW 88.1 billion in Q1 2026 and KRW 134.4 billion in Q2 (up 52.5%), then dropped to KRW 85.2 billion in Q3 2026 (down 36.6% quarter on quarter).
Q3 2026 revenue was KRW 1.67 trillion, up 3.1% year on year, yet the company swung to a net loss of KRW 1.67 trillion attributable to controlling shareholders.
Management pointed to the seasonal slowdown, raw materials bought at high prices during the cost spike, and foreign-currency translation losses in silicones from the stronger won. The net loss also reflected roughly KRW 2 trillion of valuation losses on listed shares held, including Samsung C&T.